Although FGB has been investigated as a potential biomarker for various diseases, including preeclampsia, gastric carcinoma, disseminated intravascular coagulation, and oral squamous cell carcinoma [50–53], the relationship between FGB and AVN remains unclear. This evidence concerns the gene FGB and preeclampsia.